Literature DB >> 10840558

Residual neuromuscular blockade. Incidence and relevance.

L I Eriksson1.   

Abstract

Residual neuromuscular block is a major risk factor behind critical events in the immediate postoperative period. Residual weakness due to muscle relaxants is seen in more than thirds of postoperative patients with ventilatory failure and hypoxia. Residual neuromuscular block should therefore be regarded as a serious adverse event in the same way as we regard ventilatory depression due to opioids and anaesthetic agents. This presentation aim to clarify our present knowledge and shortcomings in the field of residual neuromuscular blockade.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840558     DOI: 10.1007/s001010070008

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  2 in total

1.  Effect of Smoking on Reversing Neuromuscular Block.

Authors:  Ömür Öztürk; Gülbin Yalçın Sezen; Handan Ankaralı; Onur Özlü; Yavuz Demiraran; Hakan Ateş; Burhan Dost
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-08-01

2.  Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain.

Authors:  J Martinez-Ubieto; C Aragón-Benedí; J de Pedro; L Cea-Calvo; A Morell; Y Jiang; S Cedillo; P Ramírez-Boix; A M Pascual-Bellosta
Journal:  BMC Anesthesiol       Date:  2021-02-16       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.